GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+16.05%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$108M
AUM Growth
–
Cap. Flow
+$108M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
41.79%
Holding
59
New
52
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$10.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$5.32M |
| 3 |
Biogen
BIIB
|
$4.47M |
| 4 |
SPNC
Spectranetics Corp
SPNC
|
$4.38M |
| 5 |
Accuray
ARAY
|
$3.92M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 75.1% |
| 2 | Technology | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $10.1M | 6.24% | +135,000 | New | +$10.1M |
|
|
2
Bristol-Myers Squibb
BMY
$96B
| $5.32M | 3.27% | +100,000 | New | +$5.32M |
|
|
3
Biogen
BIIB
$19.4B
| $4.47M | 2.75% | +16,000 | New | +$4.47M |
|
|
SPNC
4
DELISTED
Spectranetics Corp
SPNC
| $4.38M | 2.69% | +175,000 | New | +$4.38M |
|
|
5
Accuray
ARAY
$157M
| $3.92M | 2.41% | +450,000 | New | +$3.92M |
|
6
Prothena Corp
PRTA
$441M
| $3.45M | 2.12% | +130,000 | New | +$3.45M |
|
|
CBST
7
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $3.44M | 2.12% | +50,000 | New | +$3.44M |
|
|
MZOR
8
DELISTED
Mazor Robotics Ltd.
MZOR
| $3.42M | 2.1% | +175,000 | New | +$3.42M |
|
9
Insmed
INSM
$28.8B
| $3.4M | 2.09% | +200,000 | New | +$3.4M |
|
|
DYAX
10
DELISTED
DYAX CORPORATION
DYAX
| $3.39M | 2.09% | +450,000 | New | +$3.39M |
|
|
HTWR
11
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $3.34M | 2.06% | +35,600 | New | +$3.34M |
|
12
Zimmer Biomet
ZBH
$21B
| $3.26M | 2.01% | +35,000 | New | +$3.26M |
|
13
Arrowhead Research
ARWR
$3.05B
| $2.98M | 1.84% | +275,000 | New | +$2.98M |
|
14
Community Health Systems
CYH
$387M
| $2.75M | 1.69% | +70,000 | New | +$2.75M |
|
15
QuidelOrtho
QDEL
$1.95B
| $2.63M | 1.62% | +85,000 | New | +$2.63M |
|
16
Puma Biotechnology
PBYI
$254M
| $2.59M | 1.59% | +25,000 | New | +$2.59M |
|
|
ACGN
17
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $2.55M | 1.57% | +550,000 | New | +$2.55M |
|
|
SGNT
18
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.54M | 1.56% | +100,000 | New | +$2.54M |
|
|
GNMK
19
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.53M | 1.55% | +190,000 | New | +$2.53M |
|
20
Bruker
BRKR
$5.16B
| $2.27M | 1.4% | +115,000 | New | +$2.27M |
|
21
Sangamo Therapeutics
SGMO
$157M
| $2.08M | 1.28% | +150,000 | New | +$2.08M |
|
|
LCI
22
DELISTED
Lannett Company, Inc.
LCI
| $1.99M | 1.22% | +60,000 | New | +$1.99M |
|
|
TRNX
23
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $1.88M | 1.16% | +100,000 | New | +$1.88M |
|
|
VOLC
24
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $1.86M | 1.14% | +85,000 | New | +$1.86M |
|
|
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.81M | 1.11% | +30,000 | New | +$1.81M |
|